Skip to content
Cardiometabolic Beat Podcast cover art

All episodes

Cardiometabolic Beat Podcast, 77 episodes.

#
Title
1

The Intersection of MASH and Cardiometabolic Risk - Part 2

2

The Intersection of MASH and Cardiometabolic Risk - Part 1

3

Case #3: A 54-Year-Old South Asian Male with a History of Cardiac Percutaneous Intervention

4

Case #2: A 62-Year-Old Diabetic Woman with an LDL-C of 53 mg/dL

5

Case #1: A 34-Year-Old Woman with Severe Heterozygous Familial Hypercholesterolemia (HeFH)

6

The Importance of Sleep Disorders and Cardiometabolic Health

7

Resiliency & Professional Career Development

8

Depression and Cardiovascular Diseases in Women

9

The Value of Being Part of the Future Leaders Program and Attending a CMHC Event - Part II

10

The Value of Being Part of the Future Leaders Program and Attending a CMHC Event - Part I

11

Expert Perspectives on Available Digital Intervention for Diabetes Care

12

Significance of Digital Health in Reducing Cardiometabolic Risks

13

Which is Better, Pharmacotherapy or Bariatric Surgery to Manage Obesity?

14

Tips and Pearls for Management of Cardio-renal Risks in Patients

15

Looking Beyond LDL-C to Address ASCVD Risk

16

Digital Health Technologies for Cardiometabolic Health: Barriers and Perspectives

17

Comprehensive Management of Type 2 Diabetes: Tips and Pearls

18

Expert Perspectives: Recap of Important Updates in Cardiometabolic Medicine 2023

19

The Value of Attending a CMHC Meeting

20

Disparities in the Management of Type 2 Diabetes in Women

21

Obesity & Lifestyle in Women

22

Unique Cardiometabolic Risk Factors in Women

23

The Link Between Chronic Inflammatory Conditions and Cardiovascular Risk

24

Cardiorenal Risk Reduction in T2DM

25

Inflammation and Current Concepts in the Treatment of Hypertension

26

Inflammation in Heart Failure

27

Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum | Episode 3: A Patient with Sleep Apnea & Comorbidities

28

Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum | Episode 2: Sodium as a Driver of Cardiovascular and Cardiometabolic Risk

29

Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum | Episode 1: Sodium Loading in Narcolepsy

30

Lifestyle, Diet, Physical Activity, and Inflammation

31

Obesity, Inflammation, and Cardiovascular Risk

32

The Utility of CGM in Type 2 Diabetes: Episode 3: Practical Pearls for Integrating CGM in Patient Care

33

The Utility of CGM in Type 2 Diabetes: Episode 2: Guidelines, Patient Selection, and Access to CGM

34

The Utility of CGM in Type 2 Diabetes: Episode 1: The Rationale for CGM in Type 2 Diabetes

35

Accelerating Diversity, Equity, and Inclusion

36

Obesity in Type 2 Diabetes Series | Episode 3: Evolution of Obesity Treatments

37

Obesity in Type 2 Diabetes Series | Episode 2: How Much Can I Do in My Practice to Address Obesity

38

Obesity in Type 2 Diabetes Series | Episode 1: How to Initiate the Conversation About Obesity in Patients with Type 2 Diabetes

39

CKD Series Episode 5: New and Emerging Therapies and Approaches for CKD

40

CKD Series Episode 4: Implications of Non-steroidal MRAs for DKD

41

CKD Series Episode 3: Updated Approach to Managing CKD in Patients with T2DM

42

CKD Series Episode 2: Counseling Patients about CKD

43

CKD Series Episode 1: Identifying Patients at Risk for DKD Onset or Progression

44

Continuous Glucose Monitoring for Patients with Anne Peters, MD

45

Treatment for Obesity for Patients with Dr Wyatt

46

The Role of Tirzepatide in Managing Type 2 Diabetes with Anne Peters, MD

47

The Role of Toxins in the Development of Cardiometabolic Diseases with Joe E. Pizzorno, ND

48

Diabetes: The Questions You Need to be Asking Your Patients with Dr Trindade

49

Food as Fuel and Her New Cookbook with Linda Shiue, MD

50

Updated 2022 ADA Standards of Care with Anne Peters, MD

51

Can We Slow the Progression of Diabetes or Reverse It?

52

Perspectives and Emerging Developments in NAFLD and NASH with Kenneth Cusi, MD

53

The Latest Cardiometabolic Concepts with Dr. George Bakris, MD

54

Emerging Strategies in Cardiometabolic Medicine with Dr. Mark Houston, MD, MS, FACP, ABAARM

55

Looming Cardiometabolic Crisis: A Conversation about Race with Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA

56

Addressing Disparities in Obesity Management with Fatima Stanford, MD

57

Making Sense of the Latest Developments with Javed Butler, MD

58

The Evolving Spectrum of Chronic Kidney Disease Treatment with Matthew R. Weir, MD

59

Food as Medicine with Linda Shiue, MD

60

VTE: A Discussion on Screening, Prevention, and Transition of Care

61

COVID-19 and New-Onset Diabetes

62

Clinical Pearls for Individualizing T2DM Therapy with SGLT2 Inhibitors and GLP-1 RAs

63

Ethnic & Racial Disparities in Cardiometabolic Health

64

Interview with Adam DeVore, MD, MHS

65

Interview with Sarah Hallberg, DO, MS, ACSM-CEP, FOMA, FNLA

66

Interview with Dr. Louis Aronne

67

Interview with Dr. Chip Lavie

68

Interview with Dr. Ahmed M. Soliman, MD

69

Interview with Dr. Jay H. Shubrook, DO, FACOFP, FAAFP

70

Sneak Peek of Spring 2021 Keynote: Call to Action - Addressing The Disproportionate Burden & Disparities with COVID-19

71

Interview with Dr. Harold Bays

72

Asian Pacific Heritage Month

73

COVID-19 and Obesity

74

COVID-19, Cardiac Injury, and Statin Therapy

75

COVID-19 and Cardiovascular Disease

76

The Use of ACE inhibitors and Angiotensin Receptor Blockers in Patients with COVID-19

77

The impact of COVID-19 in Patients with Diabetes